LIMK2 Mediates Resistance to Chemotherapeutic Drugs in Neuroblastoma Cells through Regulation of Drug-Induced Cell Cycle Arrest

• Cristina Gamell,

  Affiliation Cytoskeleton and Cancer Unit, St. Vincent’s Institute of Medical Research, Melbourne, Victoria, Australia

  ⨯
• Alice V. Schofield,

  Affiliations Cytoskeleton and Cancer Unit, St. Vincent’s Institute of Medical Research, Melbourne, Victoria, Australia, Department of Medicine at St. Vincent’s Hospital, The University of Melbourne, Melbourne, Victoria, Australia

  ⨯
• Randy Suryadinata,

  Affiliation Cell Cycle and Cancer Unit, St. Vincent’s Institute of Medical Research, Melbourne, Victoria, Australia

  ⨯
• Boris Sarcevic,

  Affiliations Cell Cycle and Cancer Unit, St. Vincent’s Institute of Medical Research, Melbourne, Victoria, Australia, Department of Medicine at St. Vincent’s Hospital, The University of Melbourne, Melbourne, Victoria, Australia

  ⨯
• Ora Bernard

  * E-mail: obernard@svi.edu.au

  Affiliations Cytoskeleton and Cancer Unit, St. Vincent’s Institute of Medical Research, Melbourne, Victoria, Australia, Department of Medicine at St. Vincent’s Hospital, The University of Melbourne, Melbourne, Victoria, Australia

  ⨯